Marc Montana

1.2k total citations
41 papers, 855 citations indexed

About

Marc Montana is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Marc Montana has authored 41 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Marc Montana's work include Synthesis and Biological Evaluation (13 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Synthesis and biological activity (6 papers). Marc Montana is often cited by papers focused on Synthesis and Biological Evaluation (13 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Synthesis and biological activity (6 papers). Marc Montana collaborates with scholars based in France, Tunisia and Italy. Marc Montana's co-authors include Patrice Vanelle, Thierry Terme, Omar Khoumeri, Christophe Curti, Pascal Rathelot, Pierre Verhaeghe, Marie‐Anne Estève, Charléric Bornet, Manon Roche and Manon Carré and has published in prestigious journals such as Tetrahedron, Molecules and International Journal of Pharmaceutics.

In The Last Decade

Marc Montana

41 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Montana France 17 490 146 95 84 55 41 855
Pascal Rathelot France 17 760 1.6× 200 1.4× 91 1.0× 38 0.5× 95 1.7× 57 1.0k
Christophe Curti France 15 393 0.8× 89 0.6× 16 0.2× 20 0.2× 118 2.1× 59 730
Karl P. Flora United States 16 91 0.2× 251 1.7× 195 2.1× 35 0.4× 72 1.3× 26 897
Huy Ngo United States 17 289 0.6× 253 1.7× 93 1.0× 33 0.4× 106 1.9× 43 812
R. Verrijk Netherlands 16 119 0.2× 378 2.6× 34 0.4× 11 0.1× 33 0.6× 37 950
Ahmed Ali Ethiopia 20 107 0.2× 161 1.1× 79 0.8× 39 0.5× 82 1.5× 44 914
Qiyong Liu United States 17 515 1.1× 349 2.4× 43 0.5× 18 0.2× 29 0.5× 33 1.3k
Daniel Cohen United States 24 1.2k 2.4× 204 1.4× 49 0.5× 16 0.2× 177 3.2× 60 2.1k
Lauren Lee United States 13 242 0.5× 167 1.1× 39 0.4× 31 0.4× 90 1.6× 37 646
Romina J. Glisoni Argentina 16 209 0.4× 222 1.5× 52 0.5× 12 0.1× 56 1.0× 34 809

Countries citing papers authored by Marc Montana

Since Specialization
Citations

This map shows the geographic impact of Marc Montana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Montana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Montana more than expected).

Fields of papers citing papers by Marc Montana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Montana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Montana. The network helps show where Marc Montana may publish in the future.

Co-authorship network of co-authors of Marc Montana

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Montana. A scholar is included among the top collaborators of Marc Montana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Montana. Marc Montana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montana, Marc, et al.. (2024). Quinoxaline derivatives: Recent discoveries and development strategies towards anticancer agents. European Journal of Medicinal Chemistry. 271. 116360–116360. 24 indexed citations
2.
Montana, Marc, et al.. (2022). Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives. Pharmaceuticals. 15(7). 781–781. 7 indexed citations
3.
4.
Montana, Marc, et al.. (2021). Quinoxaline Moiety: A Potential Scaffold against Mycobacterium tuberculosis. Molecules. 26(16). 4742–4742. 33 indexed citations
5.
Montana, Marc, et al.. (2020). Antibody–Drug Conjugates in Thoracic Malignancies: Clinical Trials Reveal Both Promise and Challenges. Targeted Oncology. 15(4). 429–448. 1 indexed citations
6.
Montana, Marc, et al.. (2019). Development and evaluation of an elective course on the pharmacist’s role in disaster management in France. Journal of Educational Evaluation for Health Professions. 16. 19–19. 10 indexed citations
7.
Roche, Manon, et al.. (2018). Methods to control anticancer chemotherapy preparations ranked by risk analysis.. PubMed. 73(5). 251–259. 9 indexed citations
8.
Montana, Marc, et al.. (2018). Efficacy and safety of nivolumab in patients with non-small cell lung cancer: a retrospective study in clinical practice. Journal of Chemotherapy. 31(2). 90–94. 11 indexed citations
9.
Montana, Marc, et al.. (2018). Antitumoral activity of quinoxaline derivatives: A systematic review. European Journal of Medicinal Chemistry. 163. 136–147. 171 indexed citations
10.
Curti, Christophe, et al.. (2018). Management of adult Clostridium difficile digestive contaminations: a literature review. European Journal of Clinical Microbiology & Infectious Diseases. 38(2). 209–231. 10 indexed citations
11.
Curti, Christophe, et al.. (2017). Environmental monitoring by surface sampling for cytotoxics: a review. Environmental Monitoring and Assessment. 189(2). 52–52. 36 indexed citations
12.
Estève, Marie‐Anne, Omar Khoumeri, Raoudha Abderrahim, et al.. (2016). Synthesis and evaluation of in vitro antiproliferative activity of new ethyl 3-(arylethynyl)quinoxaline-2-carboxylate and pyrido[4,3- b ]quinoxalin-1(2 H )-one derivatives. European Journal of Medicinal Chemistry. 124. 959–966. 33 indexed citations
13.
Picard, Camille, et al.. (2015). Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome. Pathologie Biologie. 63(3). 136–143. 30 indexed citations
14.
Montana, Marc, et al.. (2015). Les vaccins méningocciques : état des lieux et perspectives. HAL (Le Centre pour la Communication Scientifique Directe). 12 indexed citations
15.
Curti, Christophe, et al.. (2013). Efficacy and Toxicity of Factor Xa Inhibitors. Journal of Pharmacy & Pharmaceutical Sciences. 16(1). 74–74. 11 indexed citations
16.
Curti, Christophe, et al.. (2013). Actualités dans le traitement étiologique de la sclérose latérale amyotrophique. Therapies. 68(2). 93–106. 1 indexed citations
17.
Montana, Marc, et al.. (2011). Albumin-Bound Paclitaxel: The Benefit of This New Formulation in the Treatment of Various Cancers. Journal of Chemotherapy. 23(2). 59–66. 57 indexed citations
18.
Montana, Marc, et al.. (2010). Safety Review: Squalene and Thimerosal in Vaccines. Therapies. 65(6). 533–541. 16 indexed citations
19.
Vanelle, Patrice, Marc Montana, Maxime D. Crozet, et al.. (2008). Rapid Synthesis of New Azaheterocyclic Hydroxymalonate Derivatives Using TDAE Approach. Heterocycles. 75(4). 925–925. 18 indexed citations
20.
Montana, Marc, Thierry Terme, & Patrice Vanelle. (2005). Original synthesis of oxiranes via TDAE methodology: reaction of 2,2-dibromomethylquinoxaline with aromatic aldehydes. Tetrahedron Letters. 46(48). 8373–8376. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pascal Rathelot Breakdown of academic impact, for papers by Christophe Curti Breakdown of academic impact, for papers by Karl P. Flora Breakdown of academic impact, for papers by Huy Ngo Breakdown of academic impact, for papers by R. Verrijk Breakdown of academic impact, for papers by Ahmed Ali Breakdown of academic impact, for papers by Qiyong Liu Breakdown of academic impact, for papers by Daniel Cohen Breakdown of academic impact, for papers by Lauren Lee Breakdown of academic impact, for papers by Romina J. Glisoni
Rankless by CCL
2026